Study objectives: To determine whether long-term treatment with exercise th
erapy results in more favorable, disease-specific, health-related quality o
f life (HRQL) compared with short-term treatment with exercise therapy; and
to determine whether there are gender differences in disease-specific HRQL
among individuals randomized into the two treatment groups.
Design: Randomized clinical trial,
Setting: Center-based exercise therapy unit at a university.
Participants: One hundred forty patients with COPD; 118 completed trial.
Interventions: Short-term exercise therapy (3 months); long-term exercise t
herapy (18 months).
Measurements: Chronic Disease Respiratory Questionnaire (CRQ),
Results: After 3 months of treatment, there were significant improvements i
n all CRQ scores for men and women (p < 0.01), and for the total sample (p
< 0.01). At 18 months, individuals randomized into the long-term group had
significantly more favorable scores than the short-term group for dyspnea (
p = 0.03), fatigue (p < 0.01), emotional function (p = 0.04), and mastery (
p = 0.04), However, these effects were moderated by gender, That is, men in
the long-term group reported significantly more favorable scores than men
in the short-term group for dyspnea (0.04), fatigue (p < 0.001), emotional
function (p = 0.02), and mastery (p = 0.02). At the 18-month assessment, th
ere were no differences between long-term and short-term exercise therapy f
or women on any of the subscales of the CRQ,
Conclusions: Taken collectively, the CRQ data demonstrate that long-term ex
ercise therapy has little added benefit for women over short-term. exercise
therapy; however, men derive significant benefits from extended training.